TEVA
Teva Pharmaceutical Industries Limited Sponsored ADR · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Generic
- Website evapharm.com
- Employees(FY) 34004
- ISIN US8816242098
Performance
+4.59%
1W
-7.67%
1M
-5.97%
3M
+2.67%
6M
+66.0%
YTD
+76.3%
1Y
Profile
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration with MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia, as well as a collaboration with Sanofi to co-develop and co-commercialize TEV-48574 asset, a novel anti-TL1A therapy for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Technical Analysis of TEVA 2024-12-06
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-06 03:31
Teva Pharmaceutical to Divest Japanese Venture to JKI(MT Newswires)
- 2024-12-05 18:00
- 2024-12-05 05:13
Teva reports positive outcomes from episodic migraine trial in young patients(Clinical Trials Arena)
- 2024-12-05 05:00
- 2024-12-04 04:25
- 2024-12-04 02:00
- 2024-12-03 13:00
- 2024-11-28 15:00
- 2024-11-25 18:00
- 2024-11-25 05:00
- 2024-11-21 02:47
- 2024-11-18 07:29
Weekly Stock List(Argus Research)
- 2024-11-15 09:09
- 2024-11-14 12:23
Analyst Report: Teva Phar Inds Lt(Argus Research)
- 2024-11-14 12:08
Market Update: CP, TEVA, MET, IGT(Argus Research)
- 2024-11-08 16:30
- 2024-11-08 09:40
- 2024-11-08 03:30
- 2024-11-07 10:39
- 2024-11-07 08:50
- 2024-11-07 02:06
- 2024-11-06 16:06
'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe.(Investor's Business Daily)
- 2024-11-06 14:41
Analyst Report: Teva Pharmaceutical Industries Limited(Morningstar Research)
- 2024-11-06 11:30
- 2024-11-06 10:08
- 2024-11-06 09:30
- 2024-11-06 07:43
- 2024-11-06 07:00
- 2024-11-06 01:08
- 2024-11-05 19:57
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.